Electra Therapeutics, Inc. Common stock (ETRA) — Financial Flexibility Index

Latest as of December 2025: -0.46x

Electra Therapeutics, Inc. Common stock (ETRA) has a Financial Flexibility Index of -0.46x as of December 2025. Free cash flow of $-59.75 Million (operating CF $-60.48 Million minus capex $733.00K) represents 0% of total liabilities ($129.69 Million). Check Electra Therapeutics, Inc. Common stock (ETRA) asset resilience to evaluate the company's liquid asset resilience ratio.

Financial Flexibility Index

-0.46x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-59.75 Million
Operating CF − Capex

Total Liabilities

$129.69 Million
USD

Capital Expenditures

$733.00K
USD

Electra Therapeutics, Inc. Common stock Financial Flexibility Index (2024–2025)

Historical Financial Flexibility Index trend for Electra Therapeutics, Inc. Common stock across 2 annual periods. Explore Electra Therapeutics, Inc. Common stock debt service capacity to assess how comfortably operating cash covers total debt obligations.

Annual Financial Flexibility Index for Electra Therapeutics, Inc. Common stock (2024–2025)

Year-by-year free cash flow to debt coverage for Electra Therapeutics, Inc. Common stock. For the full cash flow conversion analysis, see cash efficiency ratio of Electra Therapeutics, Inc. Common stock.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -0.46x $-59.75 Million $-60.48 Million $129.69 Million ▼ -117.4%
2024 -0.21x $-26.00 Million $-26.00 Million $122.68 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities